Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

How Celebrities, Senators, Dietary Supplements Muddle Medicine

Simon M. Helfgott, MD  |  Issue: June 2015  |  June 15, 2015

As the columnist Frank Bruni recently opined in, The New York Times, there has been an unsettling corruption of academia by celebrity culture. Whether it is Harvard Professor Henry Louis Gates self-censoring his television show at the request of the actor Ben Affleck or the University of Houston spending $155,000 to schedule actor Matthew McConaughey to give its commencement address this spring, some academic institutions are blurring the lines between academic virtues and celebrity values.11

This does not bode well for any of us. To quote Thomas Paine, “Character is much easier kept than recovered.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Simon M. Helfgott, MDSimon M. Helfgott, MD, is associate professor of medicine in the Division of Rheumatology, Immunology and Allergy at Harvard Medical School in Boston.

References

  1. Epidemiologic Notes and Reports Eosinophilia-Myalgia Syndrome—New Mexico. MMWR. 1989 Nov 17;38(45):765–767.
  2. Kilbourne EM, Riagu-Perez JG, Heath CW Jr., et al. Clinical epidemiology of toxic-oil syndrome. N Engl J Med. 1983 Dec 8;309(23):1408–1414.
  3. Varga J, Uitto J, Jimenez SA. The cause and pathogenesis of the eosinophilia-myalgia syndrome. Ann Intern Med. 1992 Jan 15;116(2):140–147.
  4. Lipton E. Support is mutual for senator and Utah industry. The New York Times. 2011 Jun 20.
  5. Burros M. FDA is again proposing to regulate vitamins and supplements. The New York Times. 1993 Jun 15.
  6. Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med. 2000:343;25:1833–1838.
  7. O’Connor A. GNC to strengthen supplement quality controls. The New York Times. 2015 March 30.
  8. Cohen PA, Maller G, DeSouza R, et al. Presence of banned drugs in dietary supplements following FDA Recalls. JAMA. 2014 Oct 22–29;312(16):1691–1693.
  9. Specter M. Columbia and the problem of Dr. Oz. The New Yorker. 2015 Apr 23.
  10. Federal Trade Commission. Marketer who promoted a green coffee bean weight-loss supplement agrees to settle FTC charges. 2015 Jan 26.
  11. Bruni F. Hollywood trumps Harvard. The New York Times. 2015 April 22. http://nyti.ms/1yQYQvB.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:OpinionProfessional TopicsRheuminationsSpeak Out Rheum Tagged with:dietary supplementmedicinepatient care

Related Articles
    Kamolrat/SHUTTERSTOCK.COM

    Eosinophilia: A Diagnostic Evaluation Guide for Rheumatologists

    June 15, 2015

    Clinical Vignette A 45-year-old woman with long-standing asthma and chronic sinusitis has new-onset peripheral neuropathy, arthralgias, fatigue, progressive dyspnea and a nonproductive cough. She has never smoked and has no environmental exposures. Her medications include an albuterol metered-dose inhaler (which she uses daily); an inhaled corticosteroid, montelukast; and ibuprofen (which she takes occasionally). She is…

    How to Discuss Anti-Inflammatory Diets & Supplements with Your Patients

    June 9, 2023

    My patients ask me almost daily what kind of diet they should be on, or if there are certain supplements they should try. And a growing amount of evidence shows lifestyle and dietary factors may contribute to disease risk and outcomes in rheumatic disease. Thus, rheumatologists and rheumatology professionals are being called upon by patients…

    Gorodenkoff / shutterstock.com

    The NIAMS Diversity Supplement Program Offers Researcher Funding

    January 10, 2022

    The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is a component of the National Institutes of Health (NIH) that supports research into the causes, treatment and prevention of arthritis and musculoskeletal and skin diseases, as well as the training of basic and clinical scientists to carry out this research. NIAMS recognizes the…

    New Research Examines the Use of Natural Dietary Supplements by RA Patients

    June 4, 2019

    The popularity of natural dietary supplements has grown worldwide, with many adults using them to manage musculoskeletal conditions. But for RA patients, little is known about the risk of side effects and potential adverse drug interactions when taking these supplements with standard RA therapies. New research examined the supplement use patterns of RA patients…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences